EURORDIS-Rare Diseases Europe has received a funding boost from the EU4 Health Programme to implement the EUCAPA: European Capacity Building for Patients project.
EUCAPA is designed to train patients and their representatives in Health Technology Assessment (HTA) – the multidisciplinary and systematic process that evaluates the added value of a health technology in comparison to other existing or new ones.
Find out more about EURORDIS-Rare Diseases Europe here
Read the full reference case here and get in touch with us to find out how we can help you secure EU funding.